IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
Recruiting · NCT06349408 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors | Locally Advanced Solid Tumor | Recruiting | Phase 1 | 2026-09-25 | NCT06349408 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fortvita Biologics (USA)Inc. | 7 |
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.